Galderma unveils results from clinical trials on improvement in glabellar lines To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
New toxin receives national approval in the UK To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
Croma-Pharma unveils new toxin To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
First ready-to-use toxin to launch To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
New toxin accepted for review To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
AbobotulinumtoxinA efficacy confirmed in phase 2 study To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
Study supports botulinum toxin for treating depression To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
Croma submits toxin for EU approval To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
Positive results for liquid botulinum toxin To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »
Second Aesthetics webinar dubbed ‘excellent’ by attendees To access this post, you must purchase Annual Elite Membership, Annual Enhanced Membership or Free membership. Read More »